Target (CBDY) Receivables - Net (2016 - 2026)
Target (CBDY) reported Receivables - Net of $454765.0 for Q1 2026, down 29.56% year-over-year from $645564.0 in Q1 2025, and up 1.9% quarter-over-quarter from $446283.0 in Q4 2025.
Target (CBDY) Receivables - Net (2016 - 2026) Analysis & Trends
Target (CBDY) has 10 years of Receivables - Net data on file, last reported at $454765.0 in Q1 2026.
- Receivables - Net for Q1 2026 came in at $454765.0, down 29.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $454765.0 (down 29.56% YoY), and the FY2025 annual result was $446283.0, up 478.9% from the prior year.
- Receivables - Net grew to $454765.0 in Q1 2026 per CBDY's latest filing, from $446283.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $1.0 million in Q4 2023 and troughed at $2068.0 in Q1 2022.
- A 5-year average of $236942.1 and a median of $88699.0 in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net surged 49780.56% in 2023, then tumbled 92.53% in 2024.
- A 5-year view of Receivables - Net shows it stood at $2068.0 in 2022, then surged by 49780.56% to $1.0 million in 2023, then plunged by 92.53% to $77092.0 in 2024, then jumped by 478.9% to $446283.0 in 2025, then rose by 1.9% to $454765.0 in 2026.
- Business Quant data shows CBDY's Receivables - Net at $454765.0 in Q1 2026, $446283.0 in Q4 2025, and $312541.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454,765.00 |
| Mar 31, 2026 | 454,765.00 |
| Dec 31, 2025 | 446,283.00 |
| Dec 31, 2025 | 446,283.00 |
| Sep 30, 2025 | 312,541.00 |
| Sep 30, 2025 | 312,541.00 |
| Jun 30, 2025 | 311,894.00 |
| Jun 30, 2025 | 311,894.00 |
| Mar 31, 2025 | 645,564.00 |
| Mar 31, 2025 | 645,564.00 |
| Dec 31, 2024 | 77,092.00 |
| Dec 31, 2024 | 77,092.00 |
| Sep 30, 2024 | 46,229.00 |
| Sep 30, 2024 | 46,229.00 |
| Jun 30, 2024 | 472,766.00 |
| Jun 30, 2024 | 472,766.00 |
| Mar 31, 2024 | 88,699.00 |
| Mar 31, 2024 | 88,699.00 |
| Dec 31, 2023 | 1.03 Mn |
| Dec 31, 2023 | 1.03 Mn |